Cardiovascular Research

Evidence that blood-CSF barrier transport, but not inflammatory biomarkers, change in migraine, while CSF sVCAM1 associates with

Authors: Robert P Cowan|||Noah B Gross|||Melanie D Sweeney|||Abhay P Sagare|||Axel Montagne|||Xianghong Arakaki|||Alfred N Fonteh|||Berislav V Zlokovic|||Janice M Pogoda|||Michael G Harrington

Affiliations: + Expand

Abstract

Our objective is to explore whether blood-cerebrospinal fluid (CSF) barrier biomarkers differ in episodic migraine (EM) or chronic migraine (CM) from controls.

---

Chemical List

Biomarkers|||Vascular Cell Adhesion Molecule-1|||Fibrinogen

---

Reference List

Goadsby PJ, Holland PR, Martins‐Oliveira M, Hoffmann J, Schankin C, Akerman S. Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev. 2017;97(2):553‐622.|||Bolay H, Moskowitz MA. The emerging importance of cortical spreading depression in migraine headache. Rev Neurol. 2005;161(6‐7):655‐657.|||Levy D, Burstein R, Kainz V, Jakubowski M, Strassman AM. Mast cell degranulation activates a pain pathway underlying migraine headache. Pain. 2007;130(1‐2):166‐176.|||Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R. Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura. J Neurosci. 2010;30(26):8807‐8814.|||Hougaard A, Amin FM, Christensen CE, et al. Increased brainstem perfusion, but no blood‐brain barrier disruption, during attacks of migraine with aura. Brain. 2017;140(6):1633‐1642.|||Schulte LH, May A. The migraine generator revisited: continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain. 2016;139(Pt 7):1987‐1993.|||Welch KM, Nagesh V, Aurora SK, Gelman N. Periaqueductal gray matter dysfunction in migraine: cause or the burden of illness? Headache. 2001;41(7):629‐637.|||Brennan KC, Pietrobon D. A systems neuroscience approach to migraine. Neuron. 2018;97(5):1004‐1021.|||Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood‐brain barrier: from physiology to disease and back. Physiol Rev. 2019;99(1):21‐78.|||Ghersi‐Egea JF, Strazielle N, Catala M, Silva‐Vargas V, Doetsch F, Engelhardt B. Molecular anatomy and functions of the choroidal blood‐cerebrospinal fluid barrier in health and disease. Acta Neuropathol. 2018;135(3):337‐361.|||Ermisch A, Ruhle HJ, Landgraf R, Hess J. Blood‐brain barrier and peptides. J Cereb Blood Flow Metab. 1985;5(3):350‐357.|||Eftekhari S, Salvatore CA, Johansson S, Chen TB, Zeng Z, Edvinsson L. Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood‐brain barrier. Brain Res. 2015;1600:93‐109.|||Solar P, Zamani A, Kubickova L, Dubovy P, Joukal M. Choroid plexus and the blood‐cerebrospinal fluid barrier in disease. Fluids Barriers CNS. 2020;17(1):35.|||Schankin CJ, Maniyar FH, Seo Y, et al. Ictal lack of binding to brain parenchyma suggests integrity of the blood‐brain barrier for 11C‐dihydroergotamine during glyceryl trinitrate‐induced migraine. Brain. 2016;139(Pt 7):1994‐2001.|||Amin FM, Hougaard A, Cramer SP, et al. Intact blood‐brain barrier during spontaneous attacks of migraine without aura: a 3T DCE‐MRI study. Eur J Neurol. 2017;24(9):1116‐1124.|||Cha YH, Millett D, Kane M, Jen J, Baloh R. Adult‐onset hemiplegic migraine with cortical enhancement and oedema. Cephalalgia. 2007;27(10):1166‐1170.|||Dreier JP, Jurkat‐Rott K, Petzold GC, et al. Opening of the blood‐brain barrier preceding cortical edema in a severe attack of FHM type II. Neurology. 2005;64(12):2145‐2147.|||Hadjikhani N, Albrecht DS, Mainero C, et al. Extra‐axial inflammatory signal in parameninges in migraine with visual aura. Ann Neurol. 2020;87(6):939‐949.|||Imamura K, Takeshima T, Fusayasu E, Nakashima K. Increased plasma matrix metalloproteinase‐9 levels in migraineurs. Headache. 2008;48(1):135‐139.|||Gursoy‐Ozdemir Y, Qiu J, Matsuoka N, et al. Cortical spreading depression activates and upregulates MMP‐9. J Clin Invest. 2004;113(10):1447‐1455.|||Kovacic S, Petrinec Z, Matasin Z, et al. Increased permeability of the blood‐brain barrier following administration of glyceryl trinitrate in common carp (Cyprinus carpio L.). Coll Antropol. 2008;32(suppl. 1):99‐103.|||Burch R, Rizzoli P, Loder E. The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies. Headache. 2018;58(4):496‐505.|||Burch RC, Buse DC, Lipton RB. Migraine: epidemiology, burden, and comorbidity. Neurol Clin. 2019;37(4):631‐649.|||Headache Classification Committee of the International Headache Society (IHS) . The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629‐808.|||Harrington MG, Fonteh AN, Cowan RP, et al. Cerebrospinal fluid sodium increases in migraine. Headache. 2006;46(7):1128‐1135.|||Montagne A, Barnes S, Sweeney M, et al. Blood‐brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85(2):296‐302.|||Nation DA, Sweeney MD, Montagne A, et al. Blood‐brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med. 2019;25(2):270‐276.|||Sweeney MD, Ayyadurai S, Zlokovic BV. Pericytes of the neurovascular unit: key functions and signaling pathways. Nat Neurosci. 2016;19(6):771‐783.|||Uher T, Horakova D, Tyblova M, et al. Increased albumin quotient (QAlb) in patients after first clinical event suggestive of multiple sclerosis is associated with development of brain atrophy and greater disability 48 months later. Mult Scler. 2016;22(6):770‐781.|||Fonteh AN, Chung R, Sharma TL, et al. Cerebrospinal fluid phospholipase C activity increases in migraine. Cephalalgia. 2011;31(4):456‐462.|||Gormley P, Anttila V, Winsvold BS, et al. Meta‐analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet. 2016;48(8):856‐866.|||Gormley P, Kurki MI, Hiekkala ME, et al. Common variant burden contributes to the familial aggregation of migraine in 1,589 families. Neuron. 2018;99(5):1098.|||Hattori K, Ota M, Sasayama D, et al. Increased cerebrospinal fluid fibrinogen in major depressive disorder. Sci Rep. 2015;5:11412.|||Yousef H, Czupalla CJ, Lee D, et al. Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1. Nat Med. 2019;25(6):988‐1000.|||Yang Y, Cardarelli PM, Lehnert K, Rowland S, Krissansen GW. LPAM‐1 (integrin alpha 4 beta 7)‐ligand binding: overlapping binding sites recognizing VCAM‐1, MAdCAM‐1 and CS‐1 are blocked by fibrinogen, a fibronectin‐like polymer and RGD‐like cyclic peptides. Eur J Immunol. 1998;28(3):995‐1004.|||Dmitrieva NI, Burg MB. Elevated sodium and dehydration stimulate inflammatory signaling in endothelial cells and promote atherosclerosis. PLoS ONE. 2015;10(6):e0128870.|||Harrington MG, Chekmenev EY, Schepkin V, Fonteh AN, Arakaki X. Sodium MRI in a rat migraine model and a NEURON simulation study support a role for sodium in migraine. Cephalalgia. 2011;31(12):1254‐1265.|||Harrington MG, Fonteh AN, Arakaki X, et al. Capillary endothelial Na(+), K(+), ATPase transporter homeostasis and a new theory for migraine pathophysiology. Headache. 2010;50(3):459‐478.|||Engelhardt B, Ransohoff RM. Capture, crawl, cross: the T cell code to breach the blood‐brain barriers. Trends Immunol. 2012;33(12):579‐589.|||Ransohoff RM, Engelhardt B. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat Rev Immunol. 2012;12(9):623‐635.|||Shechter R, Miller O, Yovel G, et al. Recruitment of beneficial M2 macrophages to injured spinal cord is orchestrated by remote brain choroid plexus. Immunity. 2013;38(3):555‐569.|||Steffen BJ, Breier G, Butcher EC, Schulz M, Engelhardt B. ICAM‐1, VCAM‐1, and MAdCAM‐1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol. 1996;148(6):1819‐1838.